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Heat shock protein (HSP 72) expression i  
patients undergoing cardiac operations 
The major mammalian stress-inducible protein, heat shock protein 72, protects cells from certain 
stresses and rapidly accumulates in cells after ischemia. Heat shock protein 72 is rapidly synthesized 
in the myocardium of various species in response to ischemia, but it has not been investigated in 
human heart. To determine if heat shock protein 72 accumulated in the ischemic myocardium of 
patients undergoing cardiac operations, we obtained sequential right atrial biopsy specimens from 
12 patients undergoing repair at three intervals: before bypass, after reperfusion, and after bypass. 
Immunobiot analysis for heat shock protein 72 demonstrated a high expression in the human heart 
compared with other mammalian hearts, p(Binomial) = 0.01. Compared with before bypass, heat 
shock protein 72 contents after reperfusion and after bypass were 98.2% _+ 8.9%, p(signed-rank) = 
0.65, and 87.6% -+ 17.1%, p(signed-rank) = 0.28, respectively. Although heat shock protein 72 
concentration was unchanged in hearts after reperfusion and after bypass, the initial prebypass level 
of heat shock protein 72 was high. The high heat shock protein 72 level detected in human hearts may 
reflect preoperative disease and drug therapy, or inherently high levels may be usual in the human 
myocardium. These findings indicate that the myocardium of patients undergoing cardiac operations 
contains relatively high concentrations of heat shock protein 72, which are not increased during the 
surgical procedure. (J THORAC CARDIOVASC SURG 1995;109:370-6) 
Lynn B. McGrath, MD, Marius Locke, PhD, Michael Cane, MD, Chao Chen, PhD, and 
C. David Ianuzzo, PhD, Browns Mills, N.J. 
The risk for hospital death after cardiac surgery 
remains significant and is largely due to lack of 
scientific knowledge regarding optimal methods to 
preserve myocardial function after cardiac ischemia 
induced by periods of aortic crossclamping. 1 Modifi- 
cation of the myocardial response to ischemia during 
cardiac operations, to limit myocardial ischemia-reper- 
fusion injury, has focused on composition of the car- 
dioplegic solution, 2 methods of delivery of the solu- 
tion, 3 provision of external substrates, 4 temperature 
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manipulation, 5 and the induction of diastolic arrest 6
as strategies to preserve myocardial metabolism. 
More recently, it has been discovered that the 
heart has its own systems of protection against 
ischemia-reperfusion injury. 7 Two potential meth- 
ods of reducing myocardial injury are ischemic 
preconditioning and heat shock or stress protein 
induction. These two modalities have been shown to 
induce the major mammalian stress-inducible pro- 
tein, heat shock protein 72 (HSP 72), and both have 
potential to ameliorate the effects of myocardial 
ischemia, s Heat shock or stress proteins, HSP 72 in 
particular, may have a pivotal role as a cytoprotec- 
tive protein in this process, yet the extent o which 
HSP 72 is present in human cardiocytes has re- 
mained unknown. 9 Thus, to determine if HSP 72 
was detectable and/or accumulated in the stressed 
human myocardium, we examined HSP 72 content 
in the right atria of patients at three intervals 
(before bypass, after reperfusion, and after bypass) 
during cardiac operations. 
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Table I. Clinical and demographic variables for the 12 patients 
Patient Age (yr) Gender Diagnosis AXC (rain) CPB (rain) Procedure 
A 53.7 M CAD 13 25 CABG 
B 47.9 F MR, MS 39 61 MVR 
C 4 M VSD, PS, subvalvular AS 15 44 Resection of subvalvular AS, 
infundibular resection 
D 70.6 M CAD 30 70 CABG 
E 52.4 M CAD 31 68 CABG 
F 24.8 F AS 30 55 Resection of subvalvular AS, AVR 
G 49.4 F Partial AV canal 11 31 ASD repair 
H 65 M CAD 19 45 CABG 
I 45 M CAD 25 51 CABG 
J 19.6 M Complete AV canal 27 58 Closure of mitral cleft VSD repair 
K 9.1 F VSD, PS 12 44 Infundibular and VSD repair 
L 16.1 F ASD 5 22 ASD repair 
AS, Aortic valve stenosis;ASD, atrial septal defect;AV, atrioventricular;AVR, aortic valve replacement;AXC, aortic rossclamp time; CABG, coronary artery 
bypass grafting; CAD, coronary artery disease; CPB, cardiopulmonary bypass time; MR, mitral valve regurgitation; MS, mitral valve stenosis; MI/R, mitral valve 
replacement; PS,pulmonary stenosis; VSD, ventricular septal defect. 
Methods 
Patients. Using a protocol approved by the Institu- 
tional Review Board at Deborah Heart and Lung Center, 
Browns Mills, New Jersey, we obtained informed consent 
from all patients before they were included in the study. In 
March 1993, 12 patients underwent open intracardiac 
repair for congenital, acquired, or coronary artery disease, 
by a single surgeon (L.B.M.) (Table I). Cardiopulmonary 
bypass was established with a crystalloid-albumin prime at 
a flow rate of 2.2 L/min per square meter up to a 
maximum flow rate of 4 L/min. The patients were cooled 
to 28 ° C (nasopharyngeal), at which point the flow rate 
was reduced to 1.6 L/min per square meter. In addition to 
moderate systemic hypothermia, the methods of myocar- 
dial protection used included a single period of aortic 
crossclamping, with myocardial arrest induced by ante- 
grade infusion of cold high potassium (60 mEq/L) blood 
cardioplegic solution, with a 2:1 blood/crystalloid ratio, at 
a rate of 300 ml/min per square meter, until the septal 
temperature ached 12 ° C. A single dose of cardioplegic 
solution was administered in each case. Topical cold 
saline solution was also applied. 
Three sequential biopsies were performed of the right 
atrial free wall, from separate sites. The first biopsy 
specimen was obtained immediately after the pericardium 
was opened, after the administration of heparin, and 
before any surgical manipulation of the heart. The second 
biopsy specimen was obtained after reperfusion, 5 minutes 
after removal of the aortic crossclamp. The third biopsy 
was performed 15 minutes after the patient was weaned 
from cardiopulmonary b pass. Each biopsy sample was 
divided into three pieces to analyze for tissue HSP 72 
content, plus glycogen and lactate concentrations. The 
specimens were frozen in liquid nitrogen and stored at 
-70  ° C until analyzed. Frozen muscle samples were ho- 
mogenized in 20 volumes of sodium chloride, 600 mmol/L, 
and tris (hydroxymethyl) aminomethane (Tris), 15 
mmol/L; pH 7.5; protein concentrations were determined 
by the technique described by Lowry and associates, m 
with bovine serum albumin used as a standard. 
Lymphocyte labeling. Human lymphocytes were sub- 
jected to heat shock to determine if HSP 72 is an inducible 
protein in man. A 10 ml sample of whole blood was 
obtained from normal individuals. Blood samples were 
diluted 1:1 with minimal essential media minus methio- 
nine (Grand Island Biological Companies, Grand Island, 
N.Y.), supplemented with heparin, 2 txl/ml (1000 U/ml; 
Elkins-Sinn, Inc., Cherry Hill, N.J.), and placed in T25 
culture flasks with 10 txCi of I.-[35S]-methionine (1200 
Ci/mmol/L; New England Nuclear, Boston, Mass.). The 
flasks were incubated for 3 hours at 37 ° C or at 45 ° C for 
30 minutes and 37 ° C at 2.5 hours (heat shock). Lympho- 
cytes were isolated by placing samples over a 3.5 ml 
Ficoll-Paque solution (Pharmacia Fine Chemicals, Pisca- 
taway, N.J.) and centrifuging them for 30 minutes at 1300 
rpm in a clinical centrifuge. Lymphocytes were washed in 
phosphate-buffered saline solution. Cells were lysed in 
urea, 9 mol/L, phenylmethylsufonylfluoride, 1 mmol/L, 
and 5% B-mercaptoethanol and stored at -70  ° C before 
electrophoretic analysis. 
Radioactivity determination. Incorporation of [35S]- 
methionine was determined by precipitating an aliquot of 
the sample with cold (4 ° C) 20% trichloroacetic a id for 30 
minutes. Samples were pelleted by centrifugation at 
14,000 rpm for 3 minutes in an Eppendorf microcentri- 
fuge (Brinkman Instruments, Inc., Westbury, N.Y.), 
washed with ether, repelleted, and dried in a desiccator. 
Dried pellets were resuspended in 80 mmol/L Tris-HC1 
base (pH 6.8), 2% sodium dodecyl sulfate (SDS), 5% 
B-mercaptoethanol, and 20% glycerol, and aliquots were 
added to a Bio-Safe II cocktail (Research Products Inter- 
national, Mt. Prospect, Ill.). Radioactivity of [35S]-methi- 
onine was measured with a Beckman LS-7800 liquid 
scintillation counter (Beckman Instruments, Inc., Fuller- 
ton, Calif.). 
Polyacrylamide gel electrophoresis. One-dimensional 
SDS polyacrylamide g l electrophoresis (PAGE) was per- 
formed according to the method described by Laemmli, 11 
except that the separating els (both 0.15 × 5 cm and 
0.3 × 12 cm) consisted of a 3% to 15% polyacrylamide 
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Fig. 1. Fluorographic analyses of IEF/SDS-PAGE separated proteins from human lymphocytes labeled 
with [35S]-methionine ateither 37 ° C (control, A) or 43 ° C (heat shock, B). Stress proteins (HSP 72, HSC 
73, and HSP 90) are indicated by downward arrows. Actin (A) and a 70 kDa nonshock stress protein 
(upward arrow) whose synthesis decreased after heat shock are also included. Gels were processed as 
outlined in Methods. SDS, Sodium dodecyl sulfate; IEF, isoelectric focus. 
gradient. Two-dimensional (IEF/SDS PAGE) separation 
of proteins followed the technique of O'Farrell ~2 with 
minor modifications. The first dimension contained 60% 
pH 5 to 8 and 40% pH 3.5 to 10 ampholytes in the 
isoelectric focusing gels, and the second dimension con- 
sisted of a 3% to 15% polyacrylamide separating el 
(0.3 × 12 cm) overlaid with a 3% stacking el. Gels were 
stained with 0.5% Coomassie brilliant blue G in 50% 
methanol and 10% glacial acetic acid; they were destained 
in 50% methanol containing 10% glacial acetic acid. 
Where appropriate, low-molecular-weight standard pro- 
teins (Pharmacia Fine Chemicals, Uppsala, Sweden) were 
co-electrophoresed. Markers used were phosphorylase-b, 
94,000; albumin, 67,000; ovalbumin, 43,000; carbonic an- 
hydrase, 30,000; trypsin inhibitor, 20,100; and a lactalbu- 
min, 14,400. 
Protein transfer and immunoblotting. After electro- 
phoretic separation, proteins were transferred tonitrocel- 
lulose membranes (0.22 txm thickness; Bio-Rad Labora- 
tories, Richmond, Calif.) as described by Tobin, Staehelin, 
and Gordon, ~3 using the Bio-Rad miniprotein II gel 
transfer system. In brief, gels were equilibrated in transfer 
buffer (glycine, 192 mmol/L; Tris-C1, 25 mmol/L [pH 8.3]; 
0.1% SDS; and 20% methanol) for 5 minutes and placed 
into a sandwich consisting of a Scotchguard pad, two 
pieces of filter paper (3 mm, Whatman, Inc., Clifton, 
N.J.), nitrocellulose membrane, the gel, two more pieces 
of filter paper, and a second Scotchguard pad. All sand- 
wich components were soaked in transfer buffer before 
assembly. The sandwich and an ice pack were placed in
the transblot system and proteins were transferred to the 
nitrocellulose membrane at a constant voltage of 30 volts 
for 6 hours, with the ice pack changed at 3 hours. After 
protein transfer, the nitrocellulose membrane was blocked 
with 5% non-fat dry milk powder in Tris-buffered saline 
(TBS; NaCi 500 mmol/L, Tris-C1 20 mmol/L, pH 7.5) for 
2 hours. Blots were washed twice (5 minutes each) in
TTBS (TBS plus 0.05% Tween-20) and incubated with an 
anti-HSP 72 monoclonal antibody (Amersham Corp., 
Arlington Heights, II1., RPN.1197) in TFBS with 2% 
non-fat dry milk powder for 12 hours at 25 ° C. After two 
washes (5 minutes each) in TTBS, blots were placed in a 
solution of secondary antibody (goat-anti-mouse-immu- 
noglobulin G conjugated to alkaline phosphatase, Bio- 
Rad Laboratories) consisting of a 1:1000 dilution in TTBS 
supplemented with 2% (wt/vol) non-fat dry milk powder 
for 1 hour. Blots were washed twice in TTBS and once in 
TBS and immersed in a bicarbonate buffer (NaH2CO 3 100 
mmol/L, MgC12 1 mmol/L, pH 9.8) containing 3% (wt/vol) 
p-nitro-blue-tetrazolium chloride p-toluidine salt in 70% 
N,N-dimethyt-formamide and 15% wt/vol 5-bromo-4- 
chloro-3-indolyl phosphate in 100% N,N-dimethyl-forma- 
dine. After development, the blot was washed in water 
and photographed. Bands from immunoblots were quan- 
titated by scanning blots with a Shimadzu CS-9000U 
densitometer (Shimadzu Scientific Corp., Tokyo, Japan). 
The values for HSP 72 are presented as a ratio of the 
levels of HSP 72 found in the human right atrium, 
compared with the content of HSP 72 found in swine left 
ventricle. TM
Flnorography. Gels containing [35S]-methionine-la- 
beled proteins were processed for fluorography as de- 
scribed by Bonner and Laskey. i5 Fluorograms were pre- 
pared according to the technique of Laskey and Mills} 6 
Glycogen. Myocardial glycogen concentration was de- 
termined with the anthrone reagent as described by 
Seifter and associates. 17 In summary, the tissue samples 
used for glycogen determinations were weighed and 
quickly immersed in 30% hot potassium hydroxide until 
the tissue was completely digested (10 to 30 minutes). The 
glycogen was precipitated by the addition of 95% ethanol, 
followed by heating and cooling. After precipitation, 
glycogen was diluted in water and a sample reacted with 
sulfuric acid containing the anthrone reagent. Absorbance 
was determined spectrophotometrically at 620 nm. 
Lactate. The tissue samples used for lactate determi- 
nation were weighed, placed in cold perchloric acid, 3 
mmol/L, for 15 minutes, and then homogenized and 
centrifuged. The supernatant was then neutralized with 
potassium hydroxide, 2 mol/L, imidazole, 0.4 mol/L, plus 
potassium chloride, 0.4 mol/L, and centrifuged. The su- 
pernatant was analyzed for lactate as described by Lowry 
and Passonneau. TM 
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Fig. 2. SDS-PAGE and HSP 72 analyses from the heart of a patient with coronary artery disease. A, The 
myocardial proteins separated by SDS-PAGE and stained with Coomassie blue. B, A gel identical to that 
in A, but blotted and reacted with a monoclonal antibody for HSP 72. Both panels: lane 1, before bypass; 
lane 2, after reperfusion; lane 3, after bypass. MW, Molecular weight; S ds, standards. 
Statistical analysis. To downweight the possible outly- 
ing measurements, whenever feasible the nonparametric 
approach was adopted in performing statistical analysis. 
Spearman's rank correlation was computed to reveal the 
interrelationship between parameters. The Wilcoxon 
signed-rank test was used to detect differences between 
prebypass and postreperfusion samples. 
Results 
HSP 72 is an inducible protein in human lympho- 
cytes. Fluorographic analysis of the proteins from 
human lymphocytes separated by IEF/SDS-PAGE 
(Fig. 1) shows the enhanced synthesis of proteins 
with molecular weights of 72 kDa, 73 kDa, and 90 
kDa in heat shocked lymphocytes (Fig. 1, B). These 
proteins were synthesized at low levels in lympho- 
cytes labeled at 37 ° C (Fig. 1,A). The 73 kDa and 90 
kDa proteins are the heat shock cognate and the 90 
kDa HSP, respectively. The 72 kDa protein is the 
inducible member of the HSP 70 family, HSP 72. 
These results demonstrate hat in human lympho- 
cytes, HSP 72 is an inducible protein. 
HSP 72 is constitutively expressed in human 
myocytes. Fig. 2, A, demonstrates a Coomassie blue 
stained gel of the SDS-PAGE separated proteins 
from human heart muscle before bypass, after 
reperfusion, and after bypass. Visual inspection of 
the myosin heavy chain and actin proteins (arrow) 
demonstrates that wells were loaded with equal 
amounts of protein. Western blot of the same 
samples in Fig. 2, A, but reacted with antibody for 
HSP 72, is shown in Fig. 2, B. 
HSP 72 was detectable in all samples examined. 
To standardize the HSP 72 content among the 
various groups in human myocardial samples, hu- 
man HSP 72 values were compared with the HSP 72 
level in swine myocardium. In comparison with the 
HSP 72 content in swine heart, which is known to be 
inherently high, prebypass HSP 72 concentration 
was elevated, p(Binomial) = 0.01. According to this 
standardization, HSP 72 content was a mean of 
168% of swine left ventricular content before by- 
pass, 164% after reperfusion, and 143% after by- 
pass; therefore, HSP 72 content did not significantly 
change with e various urgical manipulations, p(F- 
test) = 0.35. 
Similarly, when expressed as percent of (preby- 
pass) control, no significant differences were noted 
in the mean HSP 72 content (_+ standard error of 
the mean) before cardiopulmonary b pass as com- 
pared with the mean postrepeffusion value (98.2% _+ 
8.9% of prebypass control), p(signed-rank) = 0.65, 
and the mean postbypass level (87.6% + 17.1% of 
prebypass control), p(signed-rank) = 0.28 (Fig. 3, A). 
There was no significant correlation among the 
groups for HSP 72 levels according to age, p(Spear- 
man) = 0.49, total aortic occlusion time, p(Spear- 
man) = 0.72, or total cardiopulmonary bypass time, 
p(Spearman) = 0.58. 
Lactate and glycogen. As a marker of metabolic 
stress in the myocardium, concentrations of lactate 
and glycogen were investigated. Graphic represen- 
tation of the values obtained for glycogen and 
lactate from atrial biopsy tissue before bypass, after 
reperfusion, and after bypass are shown in Fig. 3, B 
and C. There was no significant difference in the 
prebypass mean lactate level (9.6 p~mol/gm oftissue) 
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Fig. 3. Graphic representation f HSP 72 content (A), 
glycogen (B), and lactate (C) concentrations before by- 
pass, after reperfusion, and after bypass. 
versus postreperfusion level (11.9 txmol/gm, 
p[signed-rank] = 0.14), and postbypass level (11.3 
txmol/gm, p[signed-rank] = 0.06). 
A change in the glycogen content was observed 
between prebypass and postreperfusion values: 
mean prebypass glycogen level = 33.0 ~mol/gm of 
tissue, postreperfusion = 20.7 ~mol/gm, p(signed- 
rank) = 0.02, and postbypass = 25.0 /xmol/gm, 
p(signed-rank) = 0.41. 
Discussion 
Although various pharmacologic therapies have 
been investigated to determine their efficacy in 
enhancing tissue survival after episodes of myocar- 
dial ischemia, none has been absolutely shown to 
have the ability to reduce infarct size in animal 
models. The induction of the HSPs, which have been 
shown to be associated with cardiac protection in 
isolated heart models, have been demonstrated to 
reduce infarct size and delay the onset of irrevers- 
ible myocardial ischemic injury. 19 Five major groups 
of HSPs have been identified: the low-molecular- 
weight 22 to 30 kDa stress proteins, the 50 to 60 kDa 
stress proteins, the 70 kDa stress proteins, the 90 
kDa stress proteins, and the high-molecular-weight 
110 kDa stress proteins. 
The HSP 70 kDa family consists of at least four 
isoforms. 2° Two isoforms are induced by glucose 
deprivation and thus termed glucose-regulated pro- 
teins. Glucose-regulated protein 75 is present in the 
mitochondria, nd glucose-regulated protein 78 is 
present in the sarcoplasmic reticulum. 21A third 
isoform, the heat shock cognate, termed HSC 73, is 
a cytoplasmic protein expressed in cells during un- 
stressed conditions. 22The HSP 72 isoform is gener- 
ally a stress-inducible isoform that is absent during 
unstressed conditions but rapidly synthesized during 
or after episodes of stress. 23 A variety of proteotoxic 
(protein damaging) agents including ischemia, heat, 
ethanol, heavy metals, hypoxia, amino acid analogs, 
metabolic inhibitors, and denatured proteins have 
been shown to induce HSP 72 synthesis. 24The novel 
aspect of this study is the detection of a relatively 
high HSP 72 content in the human heart and the 
lack of an increased HSP 72 content during surgery. 
The lack of an observed increase in HSP 72 
content in this study after the period of ischemia nd 
the various urgical interventions may be related to 
several factors. First, the already high level of HSP 
72 expressed may have been sufficient for the isch- 
emic episode incurred. Second, the high constitutive 
HSP 72 content may have inhibited HSP 72 tran- 
scription, because HSP 72 has been shown to inhibit 
additional HSP 72 transcription by binding to the 
heat shock transcription factory Third, because the 
surgical procedures performed in this study were of 
a short duration (less than 2 hours), the time 
required to detect HSP 72 accumulation may have 
been insufficient. For example, in animals, although 
HSP 72 messenger ribonucleic acid has been shown 
to be rapidly induced (5 minutes in canine hearts 
after ischemia), the HSP 72 protein rises to peak 
levels 8 to 24 hours after the stress. 26 Last, because 
the only significant metabolic hange was in glyco- 
gen content between prebypass and postreperfusion 
measurements, he metabolic stresses to the heart 
during the operation may not have been severe 
enough to significantly elevate HSP 72 content. 
HSP 72 has been shown to confer thermo-toler- 
ance to cultured cells, such that cells with an in- 
creased HSP 72 content can withstand normally 
lethal temperatures. 27-29 Although the exact func- 
tion of HSP 72 remains unknown, it is thought that 
HSP 72 may protect cells from stressors by helping 
restore denatured proteins to their original 
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shape.20, 3o Because HSP 72 has been shown to 
protect cells from stresses, it remains probable that 
HSP 72 may provide a protective ffect to cardio- 
myocytes. In support of this, Currie and Tanguay 31 
have demonstrated that rats subjected to pretreat- 
ment with whole-body hyperthermia have higher 
HSP 72 levels with resultant cardiac protection from 
ischemia. Karmazyn, Mailer, and Currie 32 have 
demonstrated that 24 hours after rats were sub- 
jected to whole-body hyperthermia and the induc- 
tion of HSP 72, a faster recovery of force, rate of 
contraction, rate of relaxation, and a decreased 
release of creatine kinase was observed in hearts 
from heat-shocked rats compared with hearts from 
non-heat-shocked animals. More recently, Currie, 
Tanguay, and Kingma 33 have demonstrated that 
heat shock, and the subsequent increase in HSP 72, 
decreased infarct size in rabbits. Thus precondition- 
ing the heart to contain a high amount of HSP 72 
seems to allow the heart to endure ischemia-reper- 
fusion episodes. 
Whether the high HSP 72 level expressed in the 
hearts of these patients i related to their preexistent 
pathologic onditions and pharmacologic interven- 
tion, or simply reflects an inherently high expression 
of HSP 72, cannot be determined from the present 
study. However, it seems probable that HSP 72 is 
constitutively expressed at high levels in the normal 
human heart, because the unstressed swine heart 
also expresses a high level of HSP 72.14 Thus HSP 72 
may be required in human myocytes because it 
serves a function(s) that is specific but distinct from 
the general stress-related functions of HSP 72 in 
stressed cells, or because human myocytes are sub- 
jected to a stressful environment and require HSP 
72 for certain stress-related functions. 
The detection of a high constitutive expression of 
HSP 72 raises ome interesting questions. First, why 
is this normally stress-inducible protein present in 
the heart in such high quantities? Second, does the 
high level of HSP 72 expression oted in this study 
imply that preconditioning, with the goal of increas- 
ing preoperative HSP 72 content, is futile or unnec- 
essary? The answers remain unknown. However, 
from our findings it seems that because the HSP 72 
levels are inherently high in these patients at the 
time of operation, whatever protective benefit hat 
might be derived from this protein may already be 
occurring. Although HSP 72 content remained un- 
changed during the operations in this study, it 
remains possible that the role or function of HSP 72 
may have changed. In unstressed cells HSP 72 is 
initially located in the cytoplasm, but after exposure 
to stress HSP 72 moves to the nucleus. 34 Thus, 
although HSP 72 content remained unchanged after 
operation in this study, cellular location before and 
after bypass may have changed. Whether the intra- 
cellular location of HSP 72 in cardiomyocytes 
changes during surgery also remains to be deter- 
mined. Further analysis of these processes i essen- 
tial to our understanding of the role of HSP 72 in 
cardiac tissue. 
In summary, HSP 72 content was unchanged in
atrial biopsy tissue before bypass, after reperfusion, 
and after bypass. A high HSP 72 content was 
observed in the human heart in comparison with the 
HSP 72 content in the swine heart. Although the 
exact reason for the hearts of these patients express- 
ing HSP 72, a stress-inducible protein in most cells, 
remains unknown, it may reflect preoperative dis- 
ease or simply a high constitutive HSP 72 expres- 
sion. 
We acknowledge the technical ssistance of Patricia 
Finkbinder, Maggie Feild, and Sigrid Ianuzzo and the 
work on the manuscript by Nancy Couitt and Jeanne 
Harrison. 
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